Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MK-677 Recovery Complete Guide 2026: Comparison Table

The table below compares MK-677 recovery timelines based on cycle duration, dosage, and key physiological markers. These data points reflect clinical observations and published pharmacokinetic studies of ibutamoren washout periods. 4–8 weeks 10–15mg daily 24–4

This comparison does not assign a generated winner or score.

  • The table below compares MK-677 recovery timelines based on cycle duration, dosage, and key physiological markers. These data points reflect clinical observations and published pharmacokinetic studies of ibutamoren washout periods.
  • 4–8 weeks
  • 10–15mg daily
  • 24–48 hours
  • 21–28 days
  • 10–14 days (appetite, water retention)
  • Shortest recovery window. Ideal for first-time users evaluating tolerance
  • 8–12 weeks
  • 15–20mg daily
  • 28–35 days
  • 14–21 days (glucose, sleep architecture)
  • Standard protocol duration. Recovery straightforward with minimal metabolic disruption
  • 12–24 weeks
  • 20–25mg daily
  • 35–42 days
  • 21–28 days (receptor sensitivity, endogenous GH patterns)
  • Extended use requires structured taper. Receptor desensitisation delays full normalisation
  • 24+ weeks
  • 25mg+ daily
  • 42–56 days
  • 28–35 days (insulin sensitivity, aldosterone regulation)
  • Prolonged cycles risk extended washout. Blood work monitoring essential at weeks 4 and 6
More references

Related material